Recently, the mechanism of B cells inhibitory capacity has focused on their ability to produce IL-10, and have convincingly demonstrated that B cells producing IL-10 can limit disease in animal models of experimental autoimmune encephalomyelitis, inflammatory bowel disease, and rheumatoid arthritis. The gene discussed is IL10; the disease is inflammatory bowel disease.